Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert J Ossenkoppele

Showing results (51-60 of 193) with videos related to

Pageof 20
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
Antibody response to polysaccharide conjugate vaccines after nonmyeloablative allogeneic stem cell transplantationAafke Meerveld-Eggink, Ankie M T van der Velden, Gert J Ossenkoppele, et al.
Oncoimmunology|January 23, 2015
<i>In situ</i> loading of skin dendritic cells with apoptotic bleb-derived antigens for the induction of tumor-directed immunityJurjen M Ruben, Hetty J Bontkes, Theresia M Westers, et al.
Hemasphere|July 14, 2021
The Novel Oral BET-CBP/p300 Dual Inhibitor NEO2734 Is Highly Effective in Eradicating Acute Myeloid Leukemia Blasts and Stem/Progenitor CellsNoortje van Gils, Tania Martiañez Canales, Eline Vermue, et al.
Blood|November 20, 2015
Primary acute myeloid leukemia cells with overexpression of EVI-1 are sensitive to all-trans retinoic acidHan J M P Verhagen, Marjon A Smit, Arjo Rutten, et al.
Immunotherapy|April 6, 2011
Chronic myeloid leukemia lysate-loaded dendritic cells induce T-cell responses towards leukemia progenitor cellsTheresia M Westers, Willemijn van den Ancker, Hetty J Bontkes, et al.
Experimental Hematology|January 22, 2005
Purging of peripheral blood stem cell transplants in AML: a predictive model based on minimal residual disease burdenNicole Feller, Martine C Jansen-van der Weide, Marjolein A van der Pol, et al.
Immunotherapy|July 20, 2010
Impaired antigen presentation in neoplasia: basic mechanisms and implications for acute myeloid leukemiaMarvin M van Luijn, W van den Ancker, Martine E D Chamuleau, et al.
European Journal of Haematology|May 7, 2005
Sequential organ failure predicts mortality of patients with a haematological malignancy needing intensive careAlexander D Cornet, Aart I Issa, Arjan A van de Loosdrecht, et al.
Immunotherapy|August 2, 2013
Targeting the acute myeloid leukemic stem cell compartment by enhancing tumor cell-based vaccinesJurjen M Ruben, Lindy L Visser, Hetty J Bontkes, et al.
Leukemia|February 16, 2021
Two decades of targeted therapies in acute myeloid leukemiaDavid G J Cucchi, Tobias B Polak, Gert J Ossenkoppele, et al.
Pageof 20

Showing results (51-60 of 193) with videos related to

Sort By:
Pageof 20
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
Antibody response to polysaccharide conjugate vaccines after nonmyeloablative allogeneic stem cell transplantationAafke Meerveld-Eggink, Ankie M T van der Velden, Gert J Ossenkoppele, et al.
Oncoimmunology|January 23, 2015
<i>In situ</i> loading of skin dendritic cells with apoptotic bleb-derived antigens for the induction of tumor-directed immunityJurjen M Ruben, Hetty J Bontkes, Theresia M Westers, et al.
Hemasphere|July 14, 2021
The Novel Oral BET-CBP/p300 Dual Inhibitor NEO2734 Is Highly Effective in Eradicating Acute Myeloid Leukemia Blasts and Stem/Progenitor CellsNoortje van Gils, Tania Martiañez Canales, Eline Vermue, et al.
Blood|November 20, 2015
Primary acute myeloid leukemia cells with overexpression of EVI-1 are sensitive to all-trans retinoic acidHan J M P Verhagen, Marjon A Smit, Arjo Rutten, et al.
Immunotherapy|April 6, 2011
Chronic myeloid leukemia lysate-loaded dendritic cells induce T-cell responses towards leukemia progenitor cellsTheresia M Westers, Willemijn van den Ancker, Hetty J Bontkes, et al.
Experimental Hematology|January 22, 2005
Purging of peripheral blood stem cell transplants in AML: a predictive model based on minimal residual disease burdenNicole Feller, Martine C Jansen-van der Weide, Marjolein A van der Pol, et al.
Immunotherapy|July 20, 2010
Impaired antigen presentation in neoplasia: basic mechanisms and implications for acute myeloid leukemiaMarvin M van Luijn, W van den Ancker, Martine E D Chamuleau, et al.
European Journal of Haematology|May 7, 2005
Sequential organ failure predicts mortality of patients with a haematological malignancy needing intensive careAlexander D Cornet, Aart I Issa, Arjan A van de Loosdrecht, et al.
Immunotherapy|August 2, 2013
Targeting the acute myeloid leukemic stem cell compartment by enhancing tumor cell-based vaccinesJurjen M Ruben, Lindy L Visser, Hetty J Bontkes, et al.
Leukemia|February 16, 2021
Two decades of targeted therapies in acute myeloid leukemiaDavid G J Cucchi, Tobias B Polak, Gert J Ossenkoppele, et al.
Pageof 20